Ceyone Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 17-11-2024
- Paid Up Capital ₹ 9.92 Cr
as on 17-11-2024
- Company Age 7 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 40.55 Cr
as on 17-11-2024
- Satisfied Charges ₹ 58.00 Cr
as on 17-11-2024
- Revenue 407.89%
(FY 2023)
- Profit 136.62%
(FY 2023)
- Ebitda 840.15%
(FY 2023)
- Net Worth 4.84%
(FY 2023)
- Total Assets 37.24%
(FY 2023)
About Ceyone Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.92 Cr.
The company currently has active open charges totaling ₹40.55 Cr. The company has closed loans amounting to ₹58.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Suryanarayanareddy Gondesi, Padmaja Gondesi, Ujwal Gondesi, and One other member serve as directors at the Company.
- CIN/LLPIN
U73200AP2017PTC105750
- Company No.
105750
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Apr 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Ceyone Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ujwal Gondesi  | Director | 26-Apr-2017 | Current |
| Suryanarayanareddy Gondesi | Director | 26-Apr-2017 | Current |
| Padmaja Gondesi | Additional Director | 09-Oct-2019 | Current |
| Aishwarya Inukula | Director | 25-Jan-2020 | Current |
Financial Performance of Ceyone Life Sciences.
Ceyone Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 407.89% increase. The company also saw a substantial improvement in profitability, with a 136.62% increase in profit. The company's net worth moved up by a moderate rise of 4.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ceyone Life Sciences?
In 2023, Ceyone Life Sciences had a promoter holding of 81.12% and a public holding of 18.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sencon Systems Pvt. Ltd.Active 38 years 27 daysSuryanarayanareddy Gondesi, Padmaja Gondesi and 1 more are mutual person
- Giving Soil Network FoundationActive 3 years 7 months
Padmaja Gondesi and Aishwarya Inukula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 20 Nov 2023 | ₹40.36 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Mar 2022 | ₹1.86 M | Open |
State Bank Of India Creation Date: 29 Jul 2022 | ₹31.25 Cr | Satisfied |
How Many Employees Work at Ceyone Life Sciences?
Ceyone Life Sciences has a workforce of 95 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ceyone Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ceyone Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
